Japan formally approved Moderna and AstraZeneca’s COVID-19 vaccines on Friday, but the latter will not be used immediately because of lingering concern over very rare blood clots
Nine regions including Tokyo are already under a virus state of emergency, with the measure now being expanded to Okinawa in the south.
Until now, only the Pfizer-BioNTech was available in Japan, after being approved in February, and so far just two percent of the country’s 125 million residents are fully vaccinated.
